Bright Minds Biosciences Inc. (DRUG)

Bright Minds Biosciences Balance Sheet

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	89.05	82.91	5.72	6.75	11.63	19.76
Cash & Short-Term Investments	89.05	82.91	5.72	6.75	11.63	19.76
Cash Growth	53.80%	1349.43%	-15.23%	-41.97%	-41.15%	2370.22%
Other Receivables	0.5	0.41	0.05	0.04	0.16	0.11
Receivables	0.5	0.41	0.05	0.04	0.16	0.11
Prepaid Expenses	1.24	0.99	0.22	0.03	0.16	0.17
Total Current Assets	90.79	84.31	5.99	6.81	11.95	20.04
Property, Plant & Equipment	0.09	0.11	0.12	0.07	0.14	-
Other Intangible Assets	-	-	-	-	-	0
Total Assets	90.88	84.42	6.1	6.88	12.09	20.04
Accounts Payable	1.43	1.71	0.41	0.18	1.25	0.6
Accrued Expenses	0.06	0.54	0.04	0.03	0.16	0.04
Current Portion of Leases	0.09	0.08	0.08	0.07	0.07	-
Total Current Liabilities	1.58	2.34	0.53	0.28	1.47	0.64
Long-Term Leases	0.02	0.04	0.04	-	0.07	-
Total Liabilities	1.6	2.38	0.57	0.28	1.54	0.64
Common Stock	136.77	123.25	35.42	33.91	32.24	27.08
Retained Earnings	-54.14	-46.58	-34.35	-31.55	-24.17	-9.21
Comprehensive Income & Other	6.65	5.37	4.46	4.23	2.48	1.53
Shareholders' Equity	89.28	82.04	5.54	6.6	10.54	19.4
Total Liabilities & Equity	90.88	84.42	6.1	6.88	12.09	20.04
Total Debt	0.1	0.13	0.12	0.07	0.14	-
Net Cash (Debt)	88.94	82.78	5.6	6.67	11.49	19.76
Net Cash Growth	54.11%	1377.97%	-16.08%	-41.90%	-41.86%	2370.22%
Net Cash Per Share	12.22	12.04	1.30	1.79	4.65	11.01
Filing Date Shares Outstanding	9.79	7.79	6.99	4.46	3.74	2.37
Total Common Shares Outstanding	7.79	7.64	4.52	3.77	3.52	2.37
Working Capital	89.21	81.97	5.46	6.53	10.48	19.4
Book Value Per Share	11.47	10.74	1.22	1.75	3.00	8.20
Tangible Book Value	89.28	82.04	5.54	6.6	10.54	19.4
Tangible Book Value Per Share	11.47	10.74	1.22	1.75	3.00	8.20

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q